Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

6.08
Delayed Data
As of Feb 05
 -0.3382 / -5.27%
Today’s Change
5.00
Today|||52-Week Range
13.50
-20.08%
Year-to-Date
No recent news for Galmed Pharmaceuticals Ltd.

Today’s Trading

Previous close6.42
Today’s open6.37
Day’s range6.00 - 6.47
Volume12,407
Average volume (3 months)22,742
Market cap$67.5M
Dividend yield--
Data as of 3:59pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-125.51%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book2.15

Competitors

 Today’s
change
Today’s
% change
MSTXMast Therapeutics In...+0.01+2.45%
SNSSSunesis Pharmaceutic...+0.02+3.28%
REPHRecro Pharma Inc+0.09+1.23%
AKAOAchaogen Inc-0.03-0.78%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 29, 2016
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$0.00
Annual profit (last year)-$9.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Allen Baharaff
Chief Financial Officer
Josh Blacher
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts

Partner Offers